Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Immunocore
1342
Immunocore
Software
Enterprise Software
Market Research
Technology
Biotechnology
A world-leading biotechnologycompany with a highly innovative immune-oncology T cell receptor platform technology
Suggest edits
Type
B2c
Founded
2008
Raised
$490M
Follow us
Also headquartered in Oxford
Oxford University
Newton
Oxford Nanopore
Oxbotica
Exscientia
PQShield
Latent Logic
Contego
Navenio
University of Oxford
Companies in the same industry
Innerscope Research
Scicasts
Twitter
doublehelix design
GrandOmics
Auxilium Pharmaceuticals
OSE_IMMUNO
ALGAIA
Can Fite BioPharma (CANFY)
Allinaire Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Latest funding
Show all
$130,000,000
Venture capital (Series B) - 2020
General Atlantic
Rock Springs Capital
CCB International
+3
$40,000,000
Venture capital (Series B) - 2017
Bill & Melinda Gates Foundation
Team Size
50+
Employees
I work here
Location
Oxford
,
United Kingdom
Headquarters
Explore Oxford
Pulse 2.0
Immunocore (IMCR) Stock: Why It Increased 3.83%
$130,000,000
Venture capital (Series B)
Pulse 2.0
Clinical-Stage T Cell Receptor Biotech Company Immunocore Raises Over $130 Million
